The TRIUMPH programme spans 5,800+ participants across four global registrational trials, covering obesity, type 2 diabetes, knee osteoarthritis, sleep apnoea, chronic low back pain, and MASLD
This suggests direct anti-inflammatory effects of GLP-1 receptor activation in immune cells and vascular tissue
E.BrownJ
d , Representative images from immunohistochemical staining of Smurf1, p-PDK1 (S241), p-Akt (T308), PDK1 neddylation (K163) in tumors and matched adjacent tissue
These ADAs can neutralize effectiveness of GLP-1 agonists and cause adverse reactions
The 2016 Draelos study in Journal of Drugs in Dermatology compared a crosslinked HA serum with recombinant EGF against a fibroblast-conditioned media serum and documented meaningful improvements in skin appearance and texture [31]